...
首页> 外文期刊>Journal of Cellular Physiology >MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers
【24h】

MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers

机译:小分子核糖核酸在皮肤黑色素瘤:角色诊断和预后的生物标志物

获取原文
获取原文并翻译 | 示例
           

摘要

Melanoma is the leading cause of skin cancer deaths in the United States, and its incidence has been rising steadily for the past 30 years (Aftab, Dinger, & Perera, 2014). A more complete understanding of the molecular mechanisms that drive melanomagenesis is crucial to improve diagnosis, prognostication, and treatment of this disease. Given that melanoma survival rates are better when the disease is detected early, precise diagnostic tests for early melanoma detection would be extremely useful. In addition, as survival rates decrease drastically when the disease becomes metastatic, improved tools to more precisely identify high‐risk patients as well as to predict treatment response are necessary. The role of microRNAs (miRNAs) in melanoma biology could be the key. miRNA expression profiling has identified several miRNAs that play a crucial role in melanoma cell proliferation, migration, and invasion, as well as miRNAs involved in apoptosis and in the immune response. Here we review the most current data on the miRNAs involved in melanoma as well as their potential roles as diagnostic and prognostic biomarkers of this disease.
机译:黑色素瘤是皮肤癌的主要原因死亡在美国,和它的发病率一直稳步上升在过去30年(阿夫塔、全垒打,分子的完整理解melanomagenesis机制是至关重要的为了提高诊断、预测和治疗这种疾病。存活率疾病时更好早期发现、准确诊断测试黑色素瘤早期检测将是非常有用的。彻底当疾病转移,更精确地识别改进工具高危险病人以及预测治疗反应是必要的。小分子核糖核酸(microrna)在黑色素瘤生物学关键。确定几个microrna扮演一个至关重要的在黑素瘤细胞增殖、迁移,和入侵,以及microrna参与细胞凋亡和免疫反应。回顾microrna的最新数据参与黑色素瘤以及他们的潜力角色作为诊断和预后的生物标志物这种疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号